TOP AGO TUMOR SECRETS

Hormonal therapy remains the cure of to start with option for metastatic sufferers with endocrine-responsive breast most cancers (LoE 1a A, Back ++). The sequential use with the accessible drugs will depend on the individual pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at some time of diagnosis of relapse is usually recommended Ea